References
- Firmin RK, Killer HM. Extracorporeal membrane oxygenation. Perfusion 1999;14:291-7.
- Rais-Bahrami K, Short BL. The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 2000;24:406-17.
- Lustbader D, Fein A. Other modalities of oxygen therapy. Respir Care Clin N Am 2000;6:659-74.
- Peek GJ, Sosnowski AW. Extracorporeal membrane oxygenation for paediatric respiratory failure. Bri Med Bull 1997;53:745-56.
- Beghetti M, Rimersberger PC. Mechanical circulatory support in pediatric patients. Intensive Care Med 2000;26: 350-2.
- Dickey LA, Butler TJ, Bergmann TM, Bates ME, Null DM. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in short-term pig model. Perfusion 1994;9:327-33.
- Segesser LK. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg 1996;61:330-5.
- Ray MJ, Hales MM, Brown L, O’Brien MF, Stafford EG. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit. Ann Thorac Surg 2001;72:521-6.
- Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J 1999;45:250-63.
- Yang VC, Port FK, Kim JS, Teng CL, Till GO, Wakefield TW. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-97.
- Boigner H, Lechner E, Brock H, Golej J, Trittenwein G. Life threatening cardiopulmonary failure following protamine reversal of heparin after cardiopulmonary bypass. Paediatr Anaesth 2001;11:729-32.
- Malviya S. Monitoring and management of anticoagulation in children requiring extracorporeal circulation. Semin Thromb Hemost 1997;23:563-7.
- Mikhailidis DP. Regarding ‘heparin modulates integrin function in human platelets’. J Vasc Surg 2002;35:405-6.
- Greenbaum RA, Barradas MA, Mikhailidis DR, Jeremy JY, Evans TR, Dandona P. Effect of heparin and contrast medium on platelet function during routine cardiac catheterisation. Cardiovasc Res 1987;21:878-85.
- Sugimoto M, Miyata S. Functional property of von Willebrand factor under flowing blood. Int J Hematol 2002;75:19-24.
Copyright and license
Copyright © 2017 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
How to cite
1.
Bayrakçı B. Neutralization of Heparin for Extracorporeal Membrane Oxygenation. Turk J Pediatr Dis [Internet]. 2017 Jun. 1 [cited 2025 Jul. 8];11(2):151-2. Available from: https://turkjpediatrdis.org/article/view/467